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A new radioimmunoassay for urinary prostaglandins E. D.
Benzoni, M. Vincent, E. Jarsaillon, J. Sassard. Departement of
Physiology, Faculty of Medicine and Pharmacy, Lyon, France. In
order to assess the role of prostaglandins E (POE) in the patho-
physiology of hypertension and Bartter's syndrome, a new radio-
immunoassay was developed for their measurement. Due to the
short PGE plasmatic half-life, it appeared more interesting to study
them in urine. Urine was collected for 24 hr at 40 C and frozen until
assay. A known amount of 3H-PGE2 was added to a 2-mi aliquot to
determine the recovery of the extraction step. POE were extracted
at pH 3 with cyclohexane-ethylacetate (1:1), absorbed upon a
column of silicic acid (0.5 g), and selectively eluted with solvents
of increasing polarity. After evaporation to dryness, the residue
was dissolved in gelatin-phosphate buffer saline (pH, 7.4). The
mean recovery of this procedure was found to be 79 7.4% (so).
The POE2 antibodies used (1/28, 500 final dilution) were developed
in the rabbit and characterized by the following specificity: POE2,
100%; POE1, 158%; PG A1, B2 and F2, 0.9%. The incubates (Ab,
100 d; 3H-PGE2, 100 d; unknown, 100 d) were maintained at 40
C for 20 hr. The bound and free hormonal fractions were separated
with dextran-70 coated charcoal (0.25%:2.5%). The sensitivity of
the assay was at 1.3 pg, with a precision of 8.4%. A mean urinary
excretion of 136.6 45 ng (so) of PGE2124 hr was found in 20
normal children.
Membranous nephropathy (MN) following renal transplantation
(T). J.P. Cosyns, Y. Pirson, C. van Ypersele de Strihou, G.P.J.
Alexandre. Services d'Anatomie Pathologique, de Néphrologie et
de Transplantation, Cliniques Universitaires St-Luc, Bruxelles,
Belgique. Membranous nephropathy (MN) is an unusual lesion in
transplanted kidneys. We have observed MN in six grafts from
four patients. Biopsy was performed to assess acute rejection 20
days post-transplantation (PT) (1 case), or proteinuria with or
without nephrotic syndrome 14 to 70 months PT (5 cases). Lesions
are characterized by typical spikes (3 patients) and by diffuse
granular IgG and C3 subepitheial deposits (all patients). HB5Ag
assessed by indirect immunofluorescence was absent from all
biopsies. Initial nephropathy was polycystic kidneys (I case), MN
stage IV (1 case), unidentified glomerulonephritis (1 case), and
focal glomerular sclerosis (FGS) (1 case). It is of interest that in the
latter patient MN was found in three successive grafts, in the
absence of FGS. These data indicate that MN might be more
common than usually thought. MN may result not only from
recurrence of the initial disease, but may develop de nova in the
graft.
Antibody-coated bacteria detection by immunofluorescence: Its
assessment as a diagnostic tool for urinary infection localization by
the bladder washout technique. f.M. Descamps, B. Canarelli,
B.Coevoet, A. Fournier, J. Orfila. A miens, France. Most previous
studies have suggested that the presence of antibody-coated bacte-
ria (ACB) in urine sediment is of value in localizing the infection to
the kidneys or the prostate on the basis of simultaneous localiza-
tion only on radioclinical criteria. Since this assessment is uncer-
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tam, urinary infection was localized in this study simultaneously
by the bladder washout technique of Fairley and by the detection
of ACB in 18 patients with urinary infection without prostatitis.
The infection was considered to come from the kidneys when
more than 102 bacteria were found in the urine coming from the
ureters after the sterilizing washout of the bladder. ACB were
demonstrated with a UV microscope after incubation of the uri-
nary bacteria with a fluorescent antiglobulin serum. In 11 kidney
infections, according to the bladder washout, ACB were present in
9 cases, whereas in 7 bladder infections ACB were absent in 6
cases. In one case the disagreement was probably due to an error
of the bladder washout since renal histology of the nephrectomized
kidney showed a chronic pyelonephritis. In the 2 other cases,
disagreement was due to lack of ACB in kidney infections accord-
ing to the bladder washout. One of these cases was due to an acute
pyelonephritis. ACB were looked for in 24 other patients whose
infection was localized only on a radioclinical basis. Agreement
was observed in 13 out of 15 adults but in only 6 out of 9 children.
Disagreement was observed in one adult because of presence of
ACB in a patient with bladder diverticula, whose infection never
recovered after diverticulectomy, and in another adult with acute
pyelonephritis and no ACB. In 3 children with obvious radiological
pyelonephntis ACB were not detected. It is concluded that detec-
tion of ACB by immunofluorescence is an accurate tool to localize
urinary infection at least in adults. Its main advantage over the
bladder washout is that it is less painful and cumbersome.
Gastric acid secretion in chronic hemodialyzed patients: Statisti-
cally significant serum parameters. G. Dongradi, F. Khazine, M.
Beaugrand, Ph. Cassan, and J.P. Fendler. Service de Médecine
Interne et de Nephrologie, Centre Hospitalier Intercommunal,
Poissy, France. Gastric acid secretions were determined in 13
hemodialyzed patients who were waiting for renal transplant: basal
acid output (BAO) (2.9 2.2mEq/hr) and peak acid output (PAO)
after pentagastrin (25 11.5 mEq/hr) are not different from the
normal population. In a "step by step" multifactorial analysis, no
statistically significant parameters for BAO and PAO were found
for gastrinemia, uremia, creatininemia, and phosphoremia. On the
other hand, significant parameters for BAO were found for cal-
cemia (P < 0.01), immunoreactive serum parathormone (P <
0.05), and immunoreactive serum calcitonin (P < 0.05); a linear
regression of those three parameters (BAO = 0.45VI'H + 0.01 CT
÷ 0,11 calcium — 11.07) gives a good prediction for BAO mea-
sured value (r = 0.89; P < 0.001). The only significant parameter
for PAO is calcemia (P < 0.05), which had a negative correlation.
Membranoproliferative glomerulonephritis and Castleman's
pseudo-tumor. R. Genin, E. Justrabo, C. Devillebichot, and G.
Rjfle. Nephrology Unit Hôpital du Bocage, Dijon, Cedex, France.A 56-yr-old man was admitted in our hospital with diffuse edema
due to a nephrotic syndrome and mild renal insufficiency. Clinical
examination showed a well-delineated mass in the right iliac fossa.
Furthermore, biological investigations showed normochromic ane-
mia and polyclonal hypergammaglobulinemia: serum complement
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was depressed (both classical and alternative pathways); cryoglob-
ulinemia was negative. Renal biopsy showed membranoprolifera-
tive glomerulonephritis with endomembranous 1gM deposits. Lap-
arotomy disclosed a retroperitoneal tumor along the right iliac
vessels which had the histologic appearance of a lymphovascular
pseudo-tumor, also called Castleman's pseudo-tumor or angio-
follicular hyperplasia. Direct immunofluorescent studies of this
tissue proved the polyclonal character of the plasmocyte infiltrate.
Surgical removal of this pseudo-tumor resulted in disappearance of
clinical and biological symptoms of the nephrotic syndrome, but
renal biopsy was not performed after surgery. Such an association
seems very rare. Of 197 cases in the literature, we have found only
one case of association of Castleman's pseudo-tumor and minimal
change nephrotic syndrome (Humphreys, 1975). In this case the
anemia and the nephrotic syndrome disappeared after removal of a
mesentric pseudotumor. Castleman's pseudo-tumor may corre-
spond to lymphoid hyperplasia due to local antigenic aggression,
which may be responsible for angiogenesis and B cell proliferation.
This hyperplasia may explain the immunohematologic abnormali-
ties. In the present study, the immunologic findings do not indicate
whether the glomerulonephritis pseudo-tumor association is fortui-
tous, whether the nephritis is due to lymphoid hyperplasia, or
whether both are due to the same mechanism.
Is immune complex detection of clinical significance in chronic
glomerulonephritis? iC. Gluckman, N. Jacob, H. Beaufils, A.
Bau,nelou, H. Salah, A. German, and M. Legrain. Paris, France.
Sera of 168 patients with chronic primary or systemic lupus erythe-
matosus (SLE) glomerulonephritis (GN) were assayed for immune
complexes (IC) by two independent methods. These were a mcxli-
fled test of precipitation with polyethylene glycol (PEG) which is
based on the physicochemical properties of IC, and the inhibition
of complement-dependent lymphocyte rosette formation (RI)
which is based on their cellular reactivity. The two assays had
different reactivities, the RI being more sensitive than the PEG
test. Higher percentages of positivity of these tests were observed
in the various GN groups than in normal controls. Serial measure-
ments, however, demonstrated that IC were present only intermit-
tently in most instances. The presence of IC correlated with
disease activity in patients with focal glomerulosclerosis, membra-
nous GN, and membranoproliferative GN. In SLE, it reflected the
effects of different treatment regimens, although it had no relation-
ship with clinical symptoms. Our results suggest that these tests
are of little help in the clinical assessment of disease activity and
therapy monitoring in individual GN patients.
Uremic pericarditis: Beneficial effect of surgical pericardios-
tomy. P. Jungers, J. Zingraff. G. Brefort, A. Moynot, T. Drüeke,
N.K. Man, andJ. Crosnier. Service de Thérapeutique Néphrolo-
gique el JNSERM U 25, Hôpital Necker, Paris, France. Among
874 patients (pts) admitted to our chronic hemodialysis program
(410 from 1964 to 1971, period 1; 464 from 1972 to 1975, period II),
the overall incidence of pericarditis (P) was 21.2%. Episodes of P
were classified as early (EP) when occurring prior to or within one
month after starting dialysis or late (LP) when occurring after-
wards. Frequency of EP (107 episodes) decreased from 15.4%
(period I) to 11.2% (period Ii, P <0.05). Phosphatemia was higher
and overhydration was greater (weight excess: 9.6 1.2% vs. 3.4
0.5%, p <0.001) in P pts than in non-P uremic pts. Intensive
dialysis and fluid removal resulted in resolution of P in 91% of
cases; surgical drainage was needed in 9; one pt died of tamponade
prior to drainage. Recurrence of P was observed in 12 (non-
drained) pts (11%). Frequency of LP (54 episodes) decreased from
10.5% (period I) to 6.0% (period 11, P < 0.02). Mean predialysis
urea, creatinine, or uric acid were not different, but calcemia,
phosphatemia, phosphocalcic product, and maximal weight vana-
tions (9.6 1.2% vs. 3.4 0.5%, P <0.001) were higher in LP pts
than in others. Inadequate dialysis (52%), vascular access throm-
bosis (50%), anticoagulation (44%), infection and/or surgery (43%)
or overt hyperparathyroidism (43%) preceded LP. Intensive dialy-
sis and fluid removal resulted in P resolution in only 65% of cases;
19 pts needed surgical drainage; one Pt died from tamponade prior
to drainage. Recurrence of P was observed in 2 pts (4%), one after
drainage. Conclusion. Conservative management is effective in
nearly all patients with EP, but in LP pts, surgical drainage is often
indicated. If so, we propose limited pencardiostomy as the method
of choice.
Effect of hemorrhage on total and regional renal blood flow in
the conscious dog. N. La,neire, J.H. Stein, and L.D. Horn'itz.
G/ze,it, Belgium, and San Antonio, Texas, U.S.A. The effects of
hemorrhage on total and regional renal blood flow and the extent
to which the responses are modulated by prostaglandins were
investigated in 17 conscious dogs which had previously undergone
splenectomy. In 6 dogs, sequential hemorrhage of 10 and 20 mI/kg
of body wt resulted in no change in total renal blood flow, but at 30
mI/kg blood loss, there was a reduction from 6.09 to 3.00 ml/min/g
(P < 0.01). No redistribution in intracortical flow distribution
occurred at any level of hemorrhage. When 10 mI/kg blood loss
with subsequent reinfusion was studied before and after meclo-
phenamate administration, 5 mg/kg, i.v., in 9 normal dogs and 2
dogs with bilateral adrenalectomy and unilateral renal denervation,
there were no differences in total or regional renal flow due to this
prostaglandin synthetase inhibitor. It is concluded that in con-
scious dogs, hemorrhage has no effect on total renal blood flow
until blood volume is reduced by approximately 3% of body wt, at
which level renal vasoconstriction occurs, that redistribution of
renal cortical blood flow does not occur at any level of blood loss
from 1 to 3% of blood volume, and that prostaglandms have no
effect on renal blood flow during mild blood loss.
The basis of a therapeutic schedule in adult "minimal change"
lipoid nephrosis. A. Meyrier, and P. Simon. Hôpital Tenon and
Centre Hospitalier, Saint Brieuc, France. Thirty cases of adult
lipoid nephrosis (LN) which had been followed for 1.5 to 18 yr
were studied retrospectively. All had had one to three renal biop-
sies (10 had normal, and 20 "minimal change" glomeruli). In all, at
least one course of corticosteroid treatment had been tried. Sev-
enty-two exacerbations (EX) were observed (one in 10 patients,
two to seven in the others). Nine remissed spontaneously. In the
63 others, the evolution was as follows: I) 43 EX (proteinuria = nil
within an average of 13 days; prednisone dosage was in most cases
>0.5 mg/kg/day). 2)10 EX (remission was obtained in an average
of 45 days; prednisone dosage was 0.3 mg/kg/day). 3) 9 EX
(remission was still more delayed, low dosage.) 4) In one case LN
was totally corticoresistant. A statistical screening showed that the
duration of remission obtained after the termination of corticoste-
roid treatment was significantly correlated with the length of treat-
ment of each exacerbation (N = 51, y = 0.267 + 3.834, r = 0.62,
P <0.001) Eleven patients were treated with immunosuppressive
drugs at some time during the course of their disease, always in
association with prednisone. In one, azathioprine drastically modi-
fied the course of steroid-resistant LN and induced a 10-yr. still
lasting, remission. In six, immunosuppressive drugs seemed to
have prevented further exacerbations in multirelapsers, but pre-
vious steroid treatments had been too short. Conclusion. 1) The
majority of adult LN cases are corticosensitive if a I mg/kg/day
plateau-dose of prednisone is given for at least 45 days. 2) Short-
term relapses do not mean corticodependence, but rather a re-
bound effect after too short a treatment. 3) Long-term relapses are
rare, provided the total length of treatment is one year, and if
dosage is slowly tapered off to a stop. 4) In corticoresistant forms,
immunosuppressive therapy must be considered.
Utilization of pipemidic acid as an extraurinary antibiotic in
dialyzed and nondialyzed chronic renal patients; Kinetics of serum
and urinary concentrations. A Meyrier, C. Verger, and 0. Kouril-
sky. Hôpital Tenon, Paris, France. Pipemidic acid was utilized in
two patients with chronic renal failure for treating infections due to
gram negative germs. The first patient, who was anephiic and
treated by hemodialysis (HD), suffered from subacute enterobac-
teria cloacae endocarditis. He received a combination of gentami-
cm and pipemidic acid (5 mg/kg/day) during 3.5 months. Serum
levels of pipemidic acid (PA) reached 8.5g/ml. The 2nd patient
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developed acute bacterial interstitial nephntis in the course of E.
co/i septicemia. He was treated with a combination of colistime-
thate and PA (ii mg/kg/day) during 3 months. Serum and urinary
levels were respectively 10 2 g/m1 and 440g'ml. In both cases
the treatment was active and the tolerance was good. A study of
PA pharmacokinetics was undertaken in 13 cases of CRF and in6
patients treated by HD. It showed that: 1) There is an accumula-
tion of PA which is proportional to the impairment of the GFR,
and leads to serum levels well over the minimal bactericidal con-
centration of several gram negative bacteria. 2) The clinical toler-
ance is good up to serum levels of 20 g/ml. 3) High urinary
concentrations are still observed in cases with extreme renal func-
tion impairment. 4) The dialysance of PA is high, due to its low
mol wt (300 daltons) and low binding to serum proteins (10%). In 5-
hr dialyses the serum levels were reduced from 11.3—28 g/ml
(predialysis), to 0.5—4.5 g/ml (postdialysis). Conclusion. Pipem-
idic acid in chronic renal patients and in anurics can be used as an
extra-urinary antibiotic, provided the dosage is adapted to the
degree of renal failure and serum levels are monitored.
Intravenous pyelography (IVP) in acute renal failure (ARF).
J.F. Moreau, D. Ganei'al, f.M. Tubiana, J. V. Raust, F Daniel, J.
Affre, and JR. Michel. Necker Hospital, Paris, France. From
1969 to 1976, 146 patients with ARF (135 oligo-anuric, II non-
oliguric) underwent emergency IVP (118 [VP, 28 cavographies)
with subsequent aortic opacification. The mean dose of iodine was
0.95 g/kg of body wt (minimum dose, 0.5; maximum dose, 1.9).
Preoperative diagnosis of 67 cases of ARF due to ureteric obstruc-
tion was made before the seventh hour in 55 patients, and before
the fourth hour in 27 of these. In the remaining patients, doses
lower than 0.7 g/kg were used (3 cases) or middle exposures were
not taken (9 cases). In 6/6 prerenal circulatory failure, tubular
nephrograms (TN) were normal. In 2/2 obstruction of main renal
arteries, TN were absent. The 71 remaining ARF were 61 acute
tubular necrosis (ATN), 4 acute interstitial nephritis (AIN), and 6
acute glomerular nephropathies (AGN). In 36/61 ATN and 4/4
AIN, TN were early, faint rather than dense, and persisting. In 25/
61 ATN, TN could not be interpreted because of variations of
density induced by technical artefacts. In 2/6 AGN, TN were
slowly developing and increasingly dense; in the others, TN were
either slowly developing (3) or increasingly dense (I). Cavourogra-
phy was performed in 14 obstructive ARF, II of which by retro-
peritoneal carcinosis; caval changes were seen in 8/11. In 13/13
ATN, cavogram and aortogram were normal. In Ill obstruction of
main renal arteries, massive renal venous backfiow and no opacifi-
cation of the main renal arteries were observed. Conclusion. I)
One gram of iodine/kg of body wt IVP allows diagnosis of obstruc-
tive ARF by the sixth hour: 2) TN changes are indicative diagnos-
tic data for acute nephropathies but are often masked by technical
artefacts: 3) Cavography with subsequent aortic opacification im-
proves data given by IVP.
Macular changes in Alport's syndrome (AS). D. Perrin, C.
Zenatti, L.H. Noel, N. Hinglais, S. Delons, J.P. Grunfeld, and P.
Jungers. Clinique Nephrologique, Inserin U 25, Hópital Necker,
and Centre Edouard Rist, Paris, France. Since 1962, we have
noted in patients with AS a special fundoscopic lesion character-
ized by concentric macular changes with 1) central changes simu-
lating hole in macula; 2) peripheral concentric greyish zone; 3)
most specifically, an external perifoveal region containing small,
white, and bright granules. Biomicroscopic examination with con-
tact lenses shows that the most external lesions are very superfi-
cial, below the interna elastica, anterior to retinal vessels. Fluores-
cein angiography is normal, differentiating the present maculo-
pathy from drusen of the posterior pole. Visual acuity, color
vision, electroretinogram and electro-oculogram are usually nor-
mal. Such a lesion has been looked for in 74 patients with familial
nephritis. It was demonstrated in 21 patients (16 males and 5
females) from 17 families. Bilateral lenticonus and neural hearing
loss were constantly associated with macular changes. Twenty of
these patients were uremic, 16 had been treated by periodic hemo-
dialysis as of a mean age of 20.8 yr. In 53 patients (26 males and 27
females) no macular changes were found; no lenticonus was de-
tected, and hearing loss was present in only 22 cases. Renal
function was impaired in 13 patients (mean age, 43 yr), and 12
additional patients had been in chronic dialysis from a mean age of
27.7 yr. in all investigated members from each of 11 kindreds,
maculopathy was either found or not found. In contrast, in 3
kindreds it was documented in some but not in all members,
without apparent relationship to deafness or renal failure. Conclu-
sion. Macular changes appear characteristic of AS; they are con-
stantly associated with anterior lenticonus and hearing loss, and
frequently they are accompanied by progressive renal failure.
The mechanism of sodium retention in the nephrotic syndrome:
Role of aldosterone and glomerular filtration. F.C. Reubi and P.
Weidmann. Policlinique Universitaire de Médecine, Berne. Switz-
erland. Glomerular filtration rate (GFR), sodium clearance (Ca),
PAH clearance, and plasma aldosterone (aldo) were determined
simultaneously in 19 untreated patients with the nephrotic syn-
drome. For comparison, a group consisting of 19 normal subjects
and 41 patients with benign essential hypertension was also inves-
tigated. In the latter, there is a highly significant inverse correlation
between In CN and In aldo (r = —0.67, P< 0.001). In the nephrotic
group, these parameters also correlate significantly (r = —0.667, P
<0.002), but CNa tends to be lower for comparable aldo levels. In
this group CNa also depends on GFR (r = 0.731, P < 0.001), so
that a very close correlation is obtained between In Ca and In
GFRJaldo (r = 0.899, P <0.001). These findings strongly support
the view, still questioned by many investigators, that in the ne-
phrotic syndrome sodium retention is mediated by high aldo values
and in some patients by a reduction of GFR.
Two cas of nephrotic syndrome together with dermatologic
manifestations appearing during treatment of cystine stones by
alfa-mercapto-propionyl-glycine. R.J. Réveillaud, G. Blanc. and
M. Daudon. Hôpital de St-Cloud, France. The treatment of cys-
tine stones (CS) is difficult: a diet containing low suiphurous
amino-acids is insufficient. The alkalinization of the urine must
attain a pH fixed between 7 and 8 to modify the cystine solubility;
such treatment over a long period is practically impossible. The D-
penicillamine (DP), by structural analogy combines with cysteine
to form a disuiphurous bind, thus creating a new substance which
is eliminated by the urine and which is fifty times more soluble
than cystine; consequently the total excretion of cystine dimin-
ishes. Recently, therapeutic indications other than CS for treat-
ment with DP have been found: rheumatoid arthritis, biliaiy cir-
rhosis, pulmonary fibrosis, scleroderma, etc., but the secondary
effects have proved to be numerous and seem to be due to
immunologic phenomena, which require periodical and careful
examination of the urine. Because of its complications, DP is less
used today, having been replaced by new products based upon
similar theoretical principles, but possibly better tolerated by the
organism. One of these new products is alfa-mercapto-propionyl-
glycine, with which we have treated two patients. We observed in
one case an erythema and intestinal disorders during the first
month; after interrupting the treatment, these problems disap-
peared and did not reappear after progressively resuming the
treatment. During the following months, dozens of stones were
eliminated, assuring the emptying of part of the urinary tract. In
the second case, after 5 months of treatment a biological and
clinical nephrotic syndrome appeared together with proteinuria.
After stopping the treatment, all signs disappeared within 4
months. This new product is incontestably active, but requires the
same precautions as does DP.
Mesangial IgA glomerulonephritis in lILA identical brothers.
J.C. Sabatier, F. Ducret, S. Colon, C. Genin, andF.C. Berthoux.
Unite de Néphrologie, Hôpital de Bellevue, Saint-Etienne, Cedex,
et Laboratoire d'Anatomo-pathologie Rénale, Hôpital Edouard
Herriot, Lyon, Cedex, France. Two HLA identical brothers with
mesangial IgA glomerulonephritis are reported. Patient I devel-
oped gross hematuria at age 12 and required chronic hemodialysis
at age 20. Patient 2 presented at age 21 with gross hematuria and
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normal renal function which has remained stable during 9 months
ofobservation. These patients do not demonstrate nerve deafness,
ocular defects, or complement abnormalities. The family history
does not support a diagnosis of classical hereditary nephritis. The
identical HLA phenotypes (A 10, A32-B13, B35) suggest that this
form of glomerulonephritis may be genetically transmitted. The
HLA-B35 antigen has previously been suspected to be linked to
this disease. These observations strongly support the hypothesis
of an aberrant, genetically controlled, immune response in patients
with mesangial IgA glomemlonephritis.
Effects of protein diet on growth, renal function, and survival of
uremic rats. I. Saluskv, C. Kleinknecht, and M. Brayer. Hôpital
des Enfants Malades, Paris, France. The long-term effects of
three isocaloric diets (1, 11, and Ill) differing in protein content (14,
28, and 37%) were compared in rats aged 30 days with uremia due
to subtotal nephrectomy (N)—Nl (N= 10), NIl (N=8), Nih
(N=9)—and in controls—TI (N=8), TI! (N=8)and Till (N=8).
I) Food intake was similar in all control groups (y SEM = 78 3
kcal/day) and was significantly higher than in N groups (59 3,50
4 and 46 4 kcallday in NI, Nil, and Nil!, respectively; NI vs.
Nil!: P < 0.01). 2) in controls, growth was better with high
protein diet, and better than in the corresponding N groups except
for rats fed diet!. In uremic rats, growth was inversely related to
the diet protein content. At + one month, body length was 35.5
0.4, 35.0 0.8, and 34.0 0.3 cm in rats of groups NI, Nil, and
NIii, respectively (Ni vs. Nill, P < 0.05), and the differences
subsequently increased. 3) Progressive elevation of BUN and
serum creatinine was more important in rats fed high protein diet
(after one month: NI vs. Nh!: P < 0.01), whereas bicarbonate
remained similar in all N groups. 4) The higher the protein content,
the higher the mortality rate. At 12 weeks, 10, 62, and 77% of rats
in groups Ni, NI!, and NH! were dead with major renal lesions.
Conclusion. Protein diet above the minimal requirement for grow-
ing rats (14%) had deleterious effects on growth, renal function,
and survival in rats with moderate renal insufficiency.
Magnesium- and sodium-potassium-adenosine triphosphatase
activities in the kidney and the liver of spontaneously hypertensive
rats. J. Sassard, M.C. Biol, and M. Vincent. Department of
Physiology and Clinical Pharmacology, Faculty of Pharmacy,
Lyon, France. in order to elucidate the impaired urinary excretion
of sodium shown by the spontaneously hypertensive rats (SHR)
isolated by Okamoto, we measured the magnesium- and sodium-
potassium-ATPase activities in homogenates of the kidneys of
SHR. This study was conducted in groups of 48-week-old SHR
and normotensive control rats (NR), simultaneously selected in
our laboratory. The enzymatic activities were measured by the
method of Heller in homogenates of the cortex and outer medulla
of the kidney and in the liver. This latter was chosen as a control
organ because it is not involved in hypertension. A marked but
nonsignificant decrease in the specific sodium-potassium-ATPase
activity was found in the kidney of SHR, but not in the liver.
Magnesium-ATPase activity was significantly decreased in the
kidneys and was normal in the liver of SHR. As the sodium-
potassium-ATPase is involved in the tubular sodium reabsorption,
the decrease found in our strain of SHR cannot account for the low
sodium excretion reported in Okamoto's strain. The marked de-
crease in the magnesium-ATPase found in the kidneys appears
specific because it is not seen in the liver. It could be interpreted as
a defect in the bioenergetic metabolism probably due to the reno-
vascular damage exhibited by our 48-week-old SHR.
Studies on plasma retinol and its protein-binding complex in
chronic renal failure: Influence of therapeutic strategies. A. Tac-
quet, F. Goudaert, G. Lelièvre. and Ph. Dequied!. Hopital A.
Ca/incite, Li/Ic, France. In chronic renal failure, plasma retinol is
elevated, and its binding complex is abnormal. In this study, we
determined the effects of the therapeutic strategies on these modi-
fications: plasma values of retinol and its binding complex were
compared in 91 normal subjects, 46 untreated patients, 62 on
chronic hemodialysis or ultrafiltration, 8 on chronic peritoneal
dialysis, and 10 transplanted patients with renal transplants. We
confirmed: I) the high levels of retinol and its binding complex in
chronic renal failure, 2) the inefficacy of hemodialysis, hemoflltra-
tion, and peritoneal dialysis with regard to these abnormalities, 3)
their correction by renal transplantation. The practical conse-
quences of our findings are discussed.
Retroperitoneal fibrosis and Vesadol. A. Ta/in d'Eyzac, P. No-
/en, 1.. Yver, D. Pane, J. Aubert.Sen'ice de Néphrologie ci
Service d'Urologie, hotel Dieu, Poitiers, Cedex, France. A case
of retroperitoneal fibrosis is reported in a diabetic patient. The
kidney failure led to the discovery of a bilateral hydronephrosis
with typical ureter deviation toward the median line. For 18
months this patient was treated by Vesadol® (Buzepide, 3 mg;
butyrophenone, 0.3 mg per tablet) (4 tablets daily). Three weeks
after discontinuing the drug, the renal function returned to normal.
Similarly the IVP became normal one year after interrupting the
drug. The Vesadol, which combines an anticholinergic and a
phenothiazin, is used like methisergid for migraine.
Severe osteomalacia after subtotal parathyroidectomy (PTx) in
chronic uremic patients. J. Zingraff, T. DrOeke, J. Guéris. P.
Jt,ngers, and J. Crosnier. Clinique Nephrologique and INSERM
LI 25, !-!ôpital Necker, Paris, France. Osteomalacia is frequently
associated with hyperparathyroidism in chronic uremic patients.
On the other hand, osteomalacia has been reported as a complica-
tion of long-standing hypoparathyroidism. Among 48 patients on
maintenance hemodialysis who underwent subtotal PTx for overt
secondary hyperparathyroidism, three female patients developed
clinical and radiologic evidence of severe osteomalacia during the
6 to 60 months following surgery. None of them had prolonged
hypocalcemia and/or hypophosphatemia. They also had no clinical
evidence of gastrointestinal malabsorption. None of them received
anticonvulsant drugs during the year prior to the onset of clinical
signs of osteomalacia. Only one of the three patients had subnor-
mal plasma levels of immunoreactive parathyroid hormone
(iPTH), the two others were in the supra-normal range after PTx,
using an anti-COOH antibody. Two patients were ancphric, ex-
cluding at least in these two cases the possible role of post-Fix
changes in residual l-a-hydroxylation of 25(OH)D3. They were
supplemented with 25(OH)D3 (mean dose, 50 pg/day) for 4 to 18
months when symptoms of osteomalacia first appeared. Condo-
sian. The cause of the severe osteomalacia in these patients is not
obvious. The hypothesis is presented that striking decrease of
PTH excess may induce changes in vitamin D effects or metabo-
lism, other than inhibition of l-a-hydroxylase activity.
